A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

CoNextions Medical Announces Initial Commercial Use of CoNextions TR Tendon Repair Device

CoNextions Medical notes that a 17-year-old male patient with a severed extensor tendon of his thumb due to traumatic injury became the first outside of a clinical trial to undergo tendon repair with CoNextions Medical’s TR Tendon Repair device since the product’s recent approval in Chile, the first country to approve the device.

“[The CoNextions TR] device is an excellent alternative [to suture],” said Hernan Vielma, MD at Clinica Bupa Santiago, Chile.

Dan Gruppo, CoNextions Medical’s Executive Vice President of Global Sales and Marketing said: “This is an important step forward in our mission to improve the outcomes of tendon repairs globally. With the support of our distributor in Chile, CLP Insumos Medicos, we are working to ensure patients there have access to this advanced medical technology. Our development program in the US is accelerating, as we anticipate completing a clinical trial to support a 510(k) submission [in the coming months] to the FDA for commercial approval in the United States.”

The CoNextions TR is a stainless steel and ultra-high molecular weight polyethylene implant developed as an alternative to traditional suturing.  CoNextions TR allows surgeons to produce a rapid, strong, low profile, and reproducible repair in any lacerated or ruptured tendon appropriately sized for the device in the hand, wrist, forearm, foot, and ankle.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy